PR Newswire Asia's news > Biotechnology

 |   Title only   |   Print    Next page > 
     
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics
PHILADELPHIA , May 2, 2025 /PRNewswire/ -- Darnatein , a subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), a biotechnology company advancing design-augmented biologics, announced today that it will ...
2025-05-02T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
How latest genetic data on fertility may be an indicator of chronic disease onset and longevity
SINGAPORE , May 2, 2025 /PRNewswire/ -- Latest population studies have cast new light on genetic influences on women's reproductive lifespans and possible markers for the onset of chronic diseases. ...
2025-05-02T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
HistoIndex Secures SGD9 Million Investment to Drive Next Phase of Expansion
SINGAPORE , May 2, 2025 /PRNewswire/ -- HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital ...
2025-05-02T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
A Pivotal Phase II/III Clinical Study of Anti-HER2 Bispecific Antibody KN026 Have Met the Primary Endpoint of PFS at Interim Analysis
SUZHOU, China , May 1, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that a phase II/III ...
2025-05-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
S&E bio Receives Korea's First Approval for Exosome-Based Therapy Clinical Trial
SEOUL, South Korea , May 1, 2025 /PRNewswire/ -- S&E bio Co., Ltd. , a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food ...
2025-05-01T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
JediCare Medical has announced successful completion of its first-in-human feasibility study of the world's first-of-its-kind Pulmonary Nodule Percutaneous Sphere Resection
SHANGHAI , April 30, 2025 /PRNewswire/ -- JediCare Medical Technology Co., Ltd. a Shanghai, China based company ("the Company"), jointly with West China Hospital of Sichuan University, ...
2025-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ZEISS unveils AI-powered Research Data Platform; collaboration with Boehringer Ingelheim champions the future of personalized eye care
Showcasing the future of ophthalmic research at ARVO 2025: ...
2025-04-30T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical Equipment 
Mabwell Releases 6 Study Results of Innovative Drugs and Platforms at the 2025 AACR Annual Meeting
SHANGHAI , April 30, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, presented 6 study results of innovative drugs and platforms in ...
2025-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Genocury Biotech Annouces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy
Genocury launched the in vivo CD19 CAR-T therapy to reach the clinical stage, demonstrating exceptional safety, efficiency and durability. ...
2025-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Alphamab Oncology Presented Preclinical Data on Two Novel Bispecific ADCs at the 2025 AACR Annual Meeting
SUZHOU, China , April 30, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the preclinical data on two novel bispecific antibody-drug conjugates (ADCs) JSKN021 and JSKN022 ...
2025-04-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
  Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2025
Suntek Computer Systems Limited.
All rights reserved